Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In August 2025 , the FDA approved Wegovy for another use: to treat a type of fatty liver disease called metabolic dysfunction-associated steatohepatitis (MASH) in adults who have moderate to advanced liver scarring (fibrosis) but do not have permanent liver damage (cirrhosis)
2 Retatrutides on-treatment average was 28.3%, compared with 22.5% for Mounjaro and 20.7% for Wegovy in their separate trials
Clinical trials show that people who maintain their tirzepatide dose keep off 80 to 95 percent of weight lost, while those who stop treatment regain weight within months
Melanotan I acetate can be used for sunlight-induced skin cancers research
What does the science say
This suggested that regulation is concentrated in glial-rich border zones that control access to the brain
